.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Federal Trade Commission
Healthtrust
Harvard Business School
Cantor Fitzgerald
UBS
Dow
QuintilesIMS
Daiichi Sankyo
McKinsey

Generated: September 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070975

« Back to Dashboard
NDA 070975 describes CLONIDINE HYDROCHLORIDE, which is a drug marketed by Hikma Farmaceutica, Zydus Pharms Usa Inc, Duramed Pharms Barr, Prinston Inc, Teva, Luitpold, Mylan, Actavis Elizabeth, Frontida Biopharm, Sun Pharm Inds Inc, Warner Chilcott, Interpharm, Par Pharm, Watson Labs, Exela Pharma Scs Llc, Alembic Pharms Ltd, Fresenius Kabi Usa, Am Therap, Anchen Pharms, Chartwell Molecules, Aurolife Pharma Llc, Unichem, Yung Shin Pharm, and Impax Labs, and is included in fifty-three NDAs. It is available from fifty-six suppliers. Additional details are available on the CLONIDINE HYDROCHLORIDE profile page.

The generic ingredient in CLONIDINE HYDROCHLORIDE is chlorthalidone; clonidine hydrochloride. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorthalidone; clonidine hydrochloride profile page.

Summary for NDA: 070975

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 070975

Mechanism of ActionAdrenergic alpha2-Agonists

Suppliers and Packaging for NDA: 070975

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLONIDINE HYDROCHLORIDE
clonidine hydrochloride
TABLET;ORAL 070975 ANDA Actavis Pharma, Inc. 0228-2128 0228-2128-10 100 TABLET in 1 BOTTLE (0228-2128-10)
CLONIDINE HYDROCHLORIDE
clonidine hydrochloride
TABLET;ORAL 070975 ANDA Actavis Pharma, Inc. 0228-2128 0228-2128-50 500 TABLET in 1 BOTTLE (0228-2128-50)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.2MG
Approval Date:Dec 16, 1986TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Cipla
Queensland Health
Chinese Patent Office
Moodys
AstraZeneca
Merck
Cantor Fitzgerald
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot